Ledger.Open graph →
SEC Form D · filed August 25, 2020

NERVGEN PHARMA CORP

Offering
$5.4M
Sold
$2.2M
Exemption
Rule 506(b)
Industry
Other
Location
VANCOUVER, British Columbia, Canada
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Harold Punnett · Vancouver, British Columbia, CanadaDirectorBrian Bayley · Vancouver, British Columbia, CanadaDirectorPaul Brennan · Vancouver, British Columbia, CanadaExec · DirectorBill Radvak · Vancouver, British Columbia, CanadaDirectorAmy Franke · Vancouver, British Columbia, CanadaExecWilliam Adams · Los Angeles, CAExecMichael Abrams · Omaha, NEDirectorLloyd Mackenzie · Vancouver, British Columbia, CanadaExecAmy Franke · Vancouver, British Columbia, CanadaExecHarold Punnett · Vancouver, British Columbia, CanadaDirectorWilliam Adams · Los Angeles, CAExecBrian Bayley · SW Calgary, Alberta, CanadaDirectorMichael Abrams · Orem, UTDirectorPaul Brennan · Vancouver, British Columbia, CanadaExec · DirectorLloyd Mackenzie · Vancouver, British Columbia, CanadaExecBill Radvak · Vancouver, British Columbia, CanadaDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗